Amgen Licenses XeriJect Technology from Xeris Biopharma for Subcutaneous Tepezza Development
Amgen (NASDAQ: AMGN) has entered into a licensing agreement with Xeris Biopharma (NASDAQ: XERS) for...
Eli Lilly Secures NMPA Approval for Emgality as Preventive Migraine Treatment in China
Eli Lilly (NYSE: LLY) has received marketing approval from the National Medical Products Administration (NMPA)...
C4 Therapeutics Outlines 2024 Focus Amid 30% Workforce Reduction, Prioritizes Key Oncology Trials
C4 Therapeutics (NASDAQ: CCCC), a leader in protein degradation, announced this week its strategic focus...
Sanofi CEO Paul Hudson Rules Out GLP-1 Competition, Eyes Next-Gen Weight-Management Therapies
Paul Hudson, CEO of Sanofi (NASDAQ: SNY), stated this week that the France-based pharmaceutical company...
Corruption Investigations Target Former HSA Officials in Guizhou and Hainan Amid Nationwide Crackdown
Corruption investigations have been launched against former senior officials of the Healthcare Security Administration (HSA)...
Henlius Biotech Secures Exclusive Rights to Sermonix’s Lasofoxifene for Breast Cancer Treatment in China
Shanghai Henlius Biotech Inc. (HKG: 2696) has entered into a partnership and licensing agreement with...
GenFleet’s SLS009 Receives Fast-Track and Orphan Drug Designations from U.S. FDA for Lymphoma and Leukemia
Shanghai-based biotech GenFleet Therapeutics announced that its CDK9 inhibitor, SLS009 (GFH009), has received fast-track and...
GSK’s Acquisition of Aiolos Bio Bolsters Respiratory Medicine Portfolio with AIO-001
UK pharmaceutical giant GSK plc (LON: GSK) has announced a deal to acquire Aiolos Bio,...
WuXi AppTec Expands Peptide Manufacturing Capacity with Two New Plants in China
WuXi AppTec (HKG: 2359, SHA: 603259), a leading China-based Contract Research, Development, and Manufacturing Organization...
Sino Medical Sciences’ HT Supreme Drug-Eluting Stent System Gains Market Approval in Bangladesh
Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical device company, has announced that...
Novartis’s Cosentyx Secures Additional Indication for Psoriatic Arthritis in China
Swiss pharmaceutical giant Novartis (SWX: NOVN) has announced that its drug Cosentyx (secukinumab), which targets...
Pfizer and Genmab’s Tivdak Earns Priority Review from FDA for Full Registration
The US Food and Drug Administration (FDA) has accepted for priority review a filing from...
International Society for Cell & Gene Therapy Comments on FDA’s CAR-T Investigation
The International Society for Cell & Gene Therapy (ISCT) has published a statement addressing the...
Meizhong Jiahe Medical Debuts on Hong Kong Stock Exchange Below IPO Price
China-based Meizhong Jiahe Medical Science & Technology Development Co., Ltd has completed its initial public...
AbbVie Launches Continuous Infusion Therapy for Advanced Parkinson’s Disease in EU
AbbVie (NYSE: ABBV) has announced the launch of its dopamine replacement therapy, Produodopa (foslevodopa +...
OBI Pharma Gets US FDA Green Light for TROP2 Targeting ADC Cancer Therapy Clinical Study
OBI Pharma (4174.TWO), partner to Biosion Inc., has announced that it has received approval from...
Bio-Link Partners with Verdot to Distribute Innovative Bioprocessing Products in China
Bio-Link Biological Applied Technologies (Shanghai) Co., Ltd., a leading provider of life sciences industry solutions...
Synvida Raises Nearly RMB 200 Million in Series A Funding to Advance Clinical Studies
Synvida, a biotech company incubated by Shanghai Pharma (HKG: 2607, SHA: 601607) and Shanghai Healthcare...
Sinocare Partners with Illumina to Localize iScan Chip Scanners for Precision Health Applications
Sinocare Inc. (SHE: 300298), a China-based company, has entered into a partnership agreement with U.S....
Johnson & Johnson to Acquire Ambrx Biopharma in a Deal Valued at USD 2 Billion
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare conglomerate, has announced its intention to...